Company Overview - FOXO Technologies Inc. is a biotechnology company focused on enhancing human health and lifespan through innovative technology and product solutions across various industries [4]. Annual General Meeting - The 2024 Annual General Meeting of FOXO will take place virtually on December 31, 2024, at 9:30 am CST, allowing shareholders to vote and submit questions online [2][8]. - Shareholders of record on December 19, 2024, will be eligible to vote on the proposals presented [1]. Board of Directors and Proposals - The Board of Directors encourages shareholders to vote in favor of the proposals outlined in the Definitive Proxy Statement filed with the SEC [3]. - The CEO of FOXO, Seamus Lagan, expressed the importance of shareholder approval for directors and auditors during the upcoming meeting [8]. Business Developments - FOXO has addressed all deficiencies related to its NYSE American continued listing requirements and has acquired significant revenue-generating businesses [8]. - The company is pursuing an acquisition and growth strategy aimed at driving substantial growth and value in 2025 and beyond [8].
FOXO TECHNOLOGIES INC. ANOUNCES DETAILS OF ITS 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2024